The TINAGL1 gene makes a protein that helps cells attach to the support material around them and communicate during tissue growth and repair. This gene plays an important role in how cells move and organize, especially during early development. If the gene does not work well, these processes may be less coordinated, which can affect how tissues form and maintain their structure.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes hold the instructions for producing proteins, the parts of cells that do the work. Other genes mostly help decide when certain processes happen, where they happen, and how strongly they run. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
TINAGL1Gene function
What if the gene works
The TINAGL1 gene makes a protein in the tissue around cells. It helps cells attach to their surroundings and may support cell movement and blood vessel growth.
Risk
What if the gene does not work
Changes in the TINAGL1 gene can reduce how well cells attach to and signal through the surrounding support matrix. Milder variants may partly weaken these interactions, while more severe variants can more clearly disrupt cell movement and matrix organization.
Treatment
What does that mean for your treatment
For pathogenic or loss-of-function variants in the TINAGL1 gene, no TINAGL1-specific treatment or management approach is currently established.
Gene function
What if the gene works
If you carry the TINAGL1 gene, your body uses it to make a protein that works in the space around cells. It helps cells attach to nearby support material and respond to local signals. In day to day tissue function, this supports organized structure as cells grow, shift, and settle into place.
The TINAGL1 gene helps make a protein that lets cells grip the support material around them. This steady attachment helps cells stay in the right place and work with nearby tissue.
Its protein links with other support proteins outside cells, including laminin and fibronectin. These connections help tissues keep an organized shape as cells grow and settle.
TINAGL1 also helps fine tune messages between the tissue scaffold and the cell surface. This supports controlled cell attachment, movement, and routine activity.
By shaping how strongly cells attach, this protein helps guide normal cell movement during tissue upkeep and development. That balance lets cells move when needed while staying connected to their surroundings.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, including variation in appearance, metabolism, and the way the body reacts to environmental factors. Many variants do not produce any noticeable effect and are simply part of natural genetic variation. At times, though, a variant can more strongly change how a gene works and may contribute to, or directly cause, a genetic condition.
Genetic variants
What if the gene does not work
Variants in the TINAGL1 gene can change how much TINAGL1 protein a cell makes, how well it folds, and how effectively it is released outside the cell. This is how TINAGL1 gene variants affect protein function at a cellular level. Some changes are mild, while more severe variants can greatly reduce protein stability or leave little to no working protein, which may weaken its interactions with structural proteins and cell surface receptors.
How variants are linked to conditions
At this point, health conditions linked to TINAGL1 gene variants have not been broadly confirmed in human genetics. If you have a reported change in the TINAGL1 gene, your doctor or genetic counselor can interpret it in the context of your own health and family history.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely found in the general population. Most do not have a direct effect on health and simply reflect natural human variation. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors also play a role. In some situations, however, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the TINAGL1 gene. If a change in TINAGL1 has been found in you or your family, a doctor or genetic counselor can help explain what it may mean for your personal risk.
Inheritance of TINAGL1 variants
There is not yet a broadly confirmed, disease-specific TINAGL1 gene inheritance pattern in human genetics. Current evidence does not support describing TINAGL1 variants as clearly autosomal dominant, autosomal recessive, or X linked for a well-established TINAGL1-related condition. The TINAGL1 gene is located on chromosome 1, which is an autosome, so you inherit one copy from your mother and one copy from your father.
What does my TINAGL1 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific health condition for the TINAGL1 gene, though this can become clearer as research grows. If you have a TINAGL1 result and want to know what it could mean for relatives, a doctor or genetic counselor can explain it in the context of your exact finding and family history.
Genetic information
Genetic testing
How you find out about variants
TINAGL1 genetic testing looks for changes in the TINAGL1 gene using a blood or saliva sample. A lab reads your DNA, often through a multigene panel or broader sequencing test, to see whether a variant is present. Your results show whether a change was found and how clearly it is understood.
When should I consider getting a genetic test?
There is not yet a broadly established, TINAGL1-specific reason for genetic testing in routine care. Decisions about testing are usually based on your personal health history, symptoms, and family history with a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains depends on the condition and the type of variant involved. Over time, many other factors also shape how the body works, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same treatment may work well for one person, have less effect in another, or cause more side effects in someone else. These differences are common and are one reason medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics studies how genetic differences affect the way people respond to medications. It examines links between genes and drugs to better understand why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body handles it. This information can help support more informed, individualized treatment decisions. To explore this topic further, you can learn more in the LearnHub.
Drugs influenced by the TINAGL1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so general questions about side effects, new symptoms, or how medicines may affect you are best discussed with your doctor.
History
Researchers identified the TINAGL1 gene during studies of proteins in the kidney and surrounding tissue matrix in the late 1990s. Early naming reflected its similarity to a previously known kidney-associated antigen, which is why it became known as the TINAGL1 gene. Scientific classifications changed as researchers learned more about the gene. Over time, studies showed that it is active beyond the kidney, which broadened interest in developmental biology and cancer research. As medical science evolved, so did understanding of this gene. Today, the TINAGL1 gene is mainly recognized within laboratory and clinical research rather than through a single public milestone.